Increasing throughput of native SEC-MS in biopharmaceutical development using a tandem UHPLC setup

CUSTOMER APPLICATION NOTE 73898 Seamless LC-MS method transfer in a biopharmaceutical development laboratory Authors: Dan Bach Kristensen1, Trine Meiborg Sloth1, Martin Ørgaard1, Pernille Foged Jensen1, Krisztina Radi2 Symphogen, Ballerup, Denmark 1 Thermo Fisher Scientific, Hemel Hempstead, UK 2 Keywords: Native…

Analytical solutions for biopharmaceutical characterization and control Your partner on every step of your journey Together we can address the challenges of biotherapeutic drug development Your molecules are complex Biotherapeutics such as monoclonal antibodies, biosimilars, antibody-drug conjugates, and nucleotide-based therapies…

Biopharma Protein solutions eBook Protein therapeutics: At a glance Protein therapeutics are a type of biotherapeutics derived from genetically engineered human proteins. They offer several advantages over small-molecule drugs, allowing for more precise targeting of complex functions. Compared to chemical…

APPLICATION NOTE 73885 Complete characterization of monoclonal antibodies under native and denaturing conditions Kristina Srzentić1, Eugen Damoc2, Kai Scheffler3, Tom Buchanan4, Krisztina Radi4, Jennifer Sutton1 Thermo Fisher Scientific, 1 Cambridge, Massachusetts, US 2 Bremen, Germany 3 Germering, Germany 4 Hemel…